Oct. 28 at 8:28 PM
Spartan Capital Securities, LLC and B2i Digital are pleased to announce that PetVivo Holdings Inc (OTCQX:
$PETV) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.
The Spartan Capital Investor Conference 2025 is a B2i Digital Featured Conference. Event details and registration for the Spartan Capital Investor Conference 2025 are available at https://b2idigital.com/spartan-capital-investor-conference-2025.
Now in its second year, the conference brings together public company executive teams, institutional investors, and thought leaders from across the U.S. capital markets for strategic networking and information exchange. Taking place at the Marriott Marquis Hotel in New York, this premier event will welcome 500+ institutional and high-net-worth investors and feature presentations from 60 public and private growth companies across technology, healthcare, consumer, and other high-opportunity sectors. Attendees can expect main-stage presentations, curated one-on-one meetings, and extensive networking opportunities that connect innovative companies with sophisticated capital.
Petvivo Holdings is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for equine and companion animals. The company leverages investments in human bio-materials and medical device industries to commercialize medical devices and therapeutics for animals in a capital and time efficient way. Petvivo’s strategy involves internally developing and/or in-licensing proprietary products from human medical device companies specifically for use in pets, capitalizing on the accelerated timeline to revenues for veterinary medical devices compared to more stringently regulated pharmaceuticals.
Petvivo is led by experienced professionals including CEO, President & Director John Lai (30+ years senior executive and operational management experience); CFO Garry Lowenthal, CMC (25+ years in senior operations and finance management); Chief Business Development Officer & General Counsel John Dolan (extensive IP development and corporate counsel experience); VP of R&D and Clinical Trials Josh Wilhelm (former Director at Schulze Diabetes Institute); VP of Sales & Marketing April B. (25+ years CPG and international marketing leadership); and VP of Distributor Relations & Corporate Accounts Bryan Monninger (20+ years in the animal industry).
B2i Digital is working closely with the outstanding Spartan Capital team, including John D. Lowry (CEO), Kim Monchik (CAO), Stephen Faucetta (Managing Director), and Julia Voss-Palmer (Executive Assistant), to enhance each presenter’s reach through in-depth digital profiles and targeted outreach.
Investors can register to attend: https://www.meetmax.com/sched/event_125183/investor_reg_new.html?attendee_role_id=SPARTAN_INVESTOR_ATT.
Learn more about Petvivo Holdings at https://www.petvivo.com/investors.